PT - JOURNAL ARTICLE AU - Powers, Jenny ED - Kay, Jonathan TI - The Role of Biosimilar and Orphan Drugs in Treating Patients with Rheumatologic Disease DP - 2014 Aug 01 TA - MD Conference Express PG - 6--8 VI - 14 IP - 17 4099 - http://mdc.sagepub.com/content/14/17/6.short 4100 - http://mdc.sagepub.com/content/14/17/6.full AB - Biosimilar drugs may offer affordable targeted therapies to patients across a spectrum of rheumatologic, oncologic, and gastrointestinal diseases, but they pose unique clinical trial design and licensing issues. Governments provide incentives for developing orphan drugs that would not otherwise be cost-effective to manufacture, allowing for the possibility of effective treatment options for rare diseases, including many rheumatologic conditions.